Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Combined oxidative phosphorylation deficiency 7 (sequence analysis of C12ORF65 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 288 | 218 |
|
Otogenetics Hearing Loss and Deafness Multi-Gene NGS Panel Otogenetics United States | 123 | 129 |
|
Centogene AG - the Rare Disease Company Germany | 203 | 194 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics, part of Exact Sciences United States | 360 | 222 |
|
Deafness, Autosomal Recessive 49 (DFNB49) via the MARVELD2 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Deafness, autosomal recessive 49 (sequence analysis of MARVELD2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain | 146 | 94 |
|
Autosomal recessive hearing loss. 41-gene NGS panel. Genologica Medica Spain | 65 | 41 |
|
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 142 | 84 |
|
Deafness, autosomal recessive: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 75 | 75 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Nonsyndromic Hearing Loss NGS Panel Fulgent Genetics United States | 146 | 99 |
|
Hearing Loss Advanced Sequencing and CNV Evaluation Athena Diagnostics United States | 249 | 184 |
|
Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 198 | 157 |
|
Fulgent Genetics United States | 1 | 1 |
|
Asper Biogene Asper Biogene LLC Estonia | 83 | 79 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.